Resmed (RMD) Total Liabilities (2010 - 2026)

Resmed (RMD) has 17 years of Total Liabilities data on file, last reported at $2.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 13.45% year-over-year to $2.3 billion; the trailing twelve-month figure through Mar 2026 stood at $2.3 billion (up 13.45% YoY), and the FY2025 full-year result was $2.2 billion, up 9.87% from the prior year.
• Total Liabilities for Q1 2026 stood at $2.3 billion, up from $2.2 billion in the prior quarter.
• Across five years, Total Liabilities topped out at $2.9 billion in Q4 2022 and bottomed at $1.6 billion in Q1 2022.
• The 5-year median for Total Liabilities is $2.2 billion (2024), against an average of $2.2 billion.
• The widest annual swing landed in 2022, when Total Liabilities surged 84.91%; it then declined 23.4% in 2024.
• A 5-year view of Total Liabilities shows it stood at $2.9 billion in 2022, then fell by 17.52% to $2.4 billion in 2023, then fell by 22.07% to $1.9 billion in 2024, then gained by 15.58% to $2.2 billion in 2025, then rose by 5.03% to $2.3 billion in 2026.
• The last three Total Liabilities figures came in at $2.3 billion (Q1 2026), $2.2 billion (Q4 2025), and $2.2 billion (Q3 2025), per Business Quant data.

Peer Comparison